319 related articles for article (PubMed ID: 13678586)
1. A CBP binding transcriptional repressor produced by the PS1/epsilon-cleavage of N-cadherin is inhibited by PS1 FAD mutations.
Marambaud P; Wen PH; Dutt A; Shioi J; Takashima A; Siman R; Robakis NK
Cell; 2003 Sep; 114(5):635-45. PubMed ID: 13678586
[TBL] [Abstract][Full Text] [Related]
2. Nectin-1alpha, an immunoglobulin-like receptor involved in the formation of synapses, is a substrate for presenilin/gamma-secretase-like cleavage.
Kim DY; Ingano LA; Kovacs DM
J Biol Chem; 2002 Dec; 277(51):49976-81. PubMed ID: 12376527
[TBL] [Abstract][Full Text] [Related]
3. Amyloid beta inhibits ectodomain shedding of N-cadherin via down-regulation of cell-surface NMDA receptor.
Uemura K; Kuzuya A; Aoyagi N; Ando K; Shimozono Y; Ninomiya H; Shimohama S; Kinoshita A
Neuroscience; 2007 Mar; 145(1):5-10. PubMed ID: 17257767
[TBL] [Abstract][Full Text] [Related]
4. Presenilin 1 and cadherins: stabilization of cell-cell adhesion and proteolysis-dependent regulation of transcription.
Parisiadou L; Fassa A; Fotinopoulou A; Bethani I; Efthimiopoulos S
Neurodegener Dis; 2004; 1(4-5):184-91. PubMed ID: 16908988
[TBL] [Abstract][Full Text] [Related]
5. Characterization of sequential N-cadherin cleavage by ADAM10 and PS1.
Uemura K; Kihara T; Kuzuya A; Okawa K; Nishimoto T; Ninomiya H; Sugimoto H; Kinoshita A; Shimohama S
Neurosci Lett; 2006 Jul; 402(3):278-83. PubMed ID: 16687212
[TBL] [Abstract][Full Text] [Related]
6. Presenilin modulates Pen-2 levels posttranslationally by protecting it from proteasomal degradation.
Crystal AS; Morais VA; Fortna RR; Carlin D; Pierson TC; Wilson CA; Lee VM; Doms RW
Biochemistry; 2004 Mar; 43(12):3555-63. PubMed ID: 15035625
[TBL] [Abstract][Full Text] [Related]
7. Calsenilin regulates presenilin 1/γ-secretase-mediated N-cadherin ε-cleavage and β-catenin signaling.
Jang C; Choi JK; Na YJ; Jang B; Wasco W; Buxbaum JD; Kim YS; Choi EK
FASEB J; 2011 Dec; 25(12):4174-83. PubMed ID: 21852538
[TBL] [Abstract][Full Text] [Related]
8. Presenilin clinical mutations can affect gamma-secretase activity by different mechanisms.
Bentahir M; Nyabi O; Verhamme J; Tolia A; Horré K; Wiltfang J; Esselmann H; De Strooper B
J Neurochem; 2006 Feb; 96(3):732-42. PubMed ID: 16405513
[TBL] [Abstract][Full Text] [Related]
9. FAD mutations in presenilin-1 or amyloid precursor protein decrease the efficacy of a gamma-secretase inhibitor: evidence for direct involvement of PS1 in the gamma-secretase cleavage complex.
Xia W; Ostaszewski BL; Kimberly WT; Rahmati T; Moore CL; Wolfe MS; Selkoe DJ
Neurobiol Dis; 2000 Dec; 7(6 Pt B):673-81. PubMed ID: 11114265
[TBL] [Abstract][Full Text] [Related]
10. Aspartyl protease inhibitor pepstatin binds to the presenilins of Alzheimer's disease.
Evin G; Sharples RA; Weidemann A; Reinhard FB; Carbone V; Culvenor JG; Holsinger RM; Sernee MF; Beyreuther K; Masters CL
Biochemistry; 2001 Jul; 40(28):8359-68. PubMed ID: 11444983
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of presenilin-independent Notch signaling.
Berechid BE; Kitzmann M; Foltz DR; Roach AH; Seiffert D; Thompson LA; Olson RE; Bernstein A; Donoviel DB; Nye JS
J Biol Chem; 2002 Mar; 277(10):8154-65. PubMed ID: 11756438
[TBL] [Abstract][Full Text] [Related]
12. PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: effects of FAD mutations.
Baki L; Shioi J; Wen P; Shao Z; Schwarzman A; Gama-Sosa M; Neve R; Robakis NK
EMBO J; 2004 Jul; 23(13):2586-96. PubMed ID: 15192701
[TBL] [Abstract][Full Text] [Related]
13. Familial Alzheimer's disease mutations inhibit gamma-secretase-mediated liberation of beta-amyloid precursor protein carboxy-terminal fragment.
Wiley JC; Hudson M; Kanning KC; Schecterson LC; Bothwell M
J Neurochem; 2005 Sep; 94(5):1189-201. PubMed ID: 15992373
[TBL] [Abstract][Full Text] [Related]
14. Presenilin1/gamma-secretase promotes the EphB2-induced phosphorylation of ephrinB2 by regulating phosphoprotein associated with glycosphingolipid-enriched microdomains/Csk binding protein.
Georgakopoulos A; Xu J; Xu C; Mauger G; Barthet G; Robakis NK
FASEB J; 2011 Oct; 25(10):3594-604. PubMed ID: 21746865
[TBL] [Abstract][Full Text] [Related]
15. Activity-dependent regulation of beta-catenin via epsilon-cleavage of N-cadherin.
Uemura K; Kihara T; Kuzuya A; Okawa K; Nishimoto T; Bito H; Ninomiya H; Sugimoto H; Kinoshita A; Shimohama S
Biochem Biophys Res Commun; 2006 Jul; 345(3):951-8. PubMed ID: 16707106
[TBL] [Abstract][Full Text] [Related]
16. JLK isocoumarin inhibitors: selective gamma-secretase inhibitors that do not interfere with notch pathway in vitro or in vivo.
Petit A; Pasini A; Alves Da Costa C; Ayral E; Hernandez JF; Dumanchin-Njock C; Phiel CJ; Marambaud P; Wilk S; Farzan M; Fulcrand P; Martinez J; Andrau D; Checler F
J Neurosci Res; 2003 Nov; 74(3):370-7. PubMed ID: 14598313
[TBL] [Abstract][Full Text] [Related]
17. Gamma-secretase activity of presenilin 1 regulates acetylcholine muscarinic receptor-mediated signal transduction.
Popescu BO; Cedazo-Minguez A; Benedikz E; Nishimura T; Winblad B; Ankarcrona M; Cowburn RF
J Biol Chem; 2004 Feb; 279(8):6455-64. PubMed ID: 14625299
[TBL] [Abstract][Full Text] [Related]
18. The cytoplasmic sequence of E-cadherin promotes non-amyloidogenic degradation of A beta precursors.
Agiostratidou G; Muros RM; Shioi J; Marambaud P; Robakis NK
J Neurochem; 2006 Feb; 96(4):1182-8. PubMed ID: 16417575
[TBL] [Abstract][Full Text] [Related]
19. Aspartate mutations in presenilin and gamma-secretase inhibitors both impair notch1 proteolysis and nuclear translocation with relative preservation of notch1 signaling.
Berezovska O; Jack C; McLean P; Aster JC; Hicks C; Xia W; Wolfe MS; Kimberly WT; Weinmaster G; Selkoe DJ; Hyman BT
J Neurochem; 2000 Aug; 75(2):583-93. PubMed ID: 10899933
[TBL] [Abstract][Full Text] [Related]
20. Caspase cleaved presenilin-1 is part of active gamma-secretase complexes.
Hansson CA; Popescu BO; Laudon H; Cedazo-Minguez A; Popescu LM; Winblad B; Ankarcrona M
J Neurochem; 2006 Apr; 97(2):356-64. PubMed ID: 16539675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
